Doses pre-purchased | # of courses | Due in NZ | Medsafe Approval | |
---|---|---|---|---|
Pfizer/BioNTech | 10,000,000 | 5,000,000 | Throughout 2021 | Feb 3 / June 21 |
AstraZeneca | 7,600,000 | 3,800,000 | End August 2021 | July 22 |
Janssen Round One | 2,000,000 | 2,000,000 | Second half 2021 | July 7 |
Novovax | 10,720,000 | 5,360,000 | Second half 2021 | Applied |
Janssen Round Two | 3,000,000 | 3,000,000 | First half 2022 | July 7 |